Respiratory

Respiratory failure impacts millions annually in the U.S., leaving many survivors with lasting physical, cognitive, and quality-of-life impairments.

A newly published study highlights a critical connection between inhalation injury severity and the risk of developing nosocomial pneumonia (NP) in burn patients.

New evidence-based guidelines for red blood cell (RBC) transfusions in critically ill patients have been released, offering critical care practitioners a roadmap to optimize patient outcomes.

A recent study examining real-world COPD treatment outcomes has highlighted safety concerns regarding single-inhaler triple therapy compared to the long-acting beta2-agonist (LABA) and inhaled corticosteroid (ICS) combination, particularly in terms of cardiovascular risks.

New research highlights the critical role Aspergillus species play in bronchiectasis, a chronic lung condition marked by airway damage.

Pulmonary hypertension (PH), a life-threatening condition, is commonly seen in patients with interstitial lung disease (ILD), significantly increasing their risk of morbidity and mortality.

Emerging data highlights a critical complication for patients with metastatic lung cancer undergoing treatment with immune checkpoint inhibitors (ICIs), including PD-1 and PD-L1 blockers.

Benralizumab, a monoclonal antibody targeting eosinophilic inflammation, outperformed prednisolone alone in treating acute exacerbations of asthma and COPD in a new study.